We herein report a patient with demyelinating inferior alveolar nerve hypertrophy, which was initially suspected to have a nerve tumor. A 39-year-old woman with childhood-onset polyneuropathy presented with tooth pain and visited a dental clinic. An X-ray examination of the mandible revealed enlargement of the mandibular canal, and a nerve tumor was suspected. CT scan and MRI showed hypertrophy of the inferior alveolar nerve along its entire length. We diagnosed the patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), which was supported by the spontaneous recovery reported in her childhood, the results from a nerve conduction study and MRI data. CIDP should be considered in the differential diagnosis of mandibular canal enlargement.
Introduction
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), an acquired immune-mediated peripheral nerve disorder, causes nerve hypertrophy. Approximately 70% of patients with CIDP have enlarged nerves in some part of the body (1) . Spinal nerve roots and brachial and lumbar plexus are the most common sites of nerve hypertrophy (2) . However, cranial nerve involvement in CIDP is rare. We herein report a patient with suspected CIDP and inferior alveolar nerve hypertrophy, which mimicked an intraosseous inferior alveolar nerve tumor.
Case Report
The patient was a 39-year-old woman who had presented with walking difficulty at age 3. She had no family history of neuromuscular disease and her physical growth and development from birth to 3 years of age were normal. Although she could not stand up and walk at age 4, her symptoms spontaneously recovered and she was to be able to walk again by age 6 with residual equinus feet and muscular atrophy in the distal extremities. She underwent an operation at age 12 to elongate the Achilles tendon. When she was 24 years old, she felt a tingling sensation in her left ring and little fingers. Nerve enlargement was detected in the upper arm segment of the ulnar nerve on the left side. A peripheral nerve schwannoma was suspected and an open biopsy was performed. However, the details of the biopsy were not available.
The patient visited our hospital at 33 years of age. An examination showed severe weakness and atrophy in her small hand muscles and lower legs. However, the proximal muscles were preserved. She did not present with pes cavus and walked with a steppage gait. The patient's tendon reflexes were diminished in the legs but normoactive in the arms. Palpable, enlarged nerves, which corresponded to the ulnar nerve, were observed in the upper arms bilaterally. The patient had decreased light touch and pain sensations in her fingertips and distal part of the legs. Her cranial nerve functions and autonomic nervous system were intact. A nerve conduction study showed excessive temporal dispersions of proximal compound muscle action potentials in the median (Fig. 1) . The motor nerve conduction velocities had also decreased. However, distal motor latencies were preserved in the median and ulnar nerves. Compound muscle action potentials were not evoked in the lower extremities. Sensory nerve action potentials were absent in the median, ulnar and sural nerves. The cerebrospinal fulid showed normal protein concentration (19 mg/dL, normal <45) with normal cellularity and M-proteinemia was not present. Duplication of the PMP22 gene by fluorescence in situ hybridization and a mutation in the MPZ gene were not detected. Based on the patient's clinical and neurophysiological features, and the presence of nerve enlargements without a family history, we diagnosed her with possible CIDP (2) . Because her symptoms had remained unchanged for at least 20 years, the patient was followed without additional treatment.
At age 39, the patient visited a dental clinic because of tooth pain. Although her facial sensation was intact, a routine X-ray examination revealed an enlargement of the mandibular canal. An inferior alveolar nerve tumor was suspected ( Fig. 2A) . CT scan and MRI showed enlargement of the bilateral inferior alveolar nerves ( Fig. 2B-D) . Reconstructed 3D-MRI showed an enlargement of the inferior alveolar nerves throughout their lengths, predominantly on the left side ( Fig. 2E-G) . MRI and ultrasonographic examination revealed nerve hypertrophy in the brachial plexus and upper arm segment of the ulnar nerves bilaterally. Hypertrophic inferior alveolar nerves due to CIDP were suspected. The patient's nerve hypertrophy did not change during a three-year follow-up period.
Discussion
Peripheral nerve hypertrophy is one of the supportive diagnostic features of CIDP (2) . However, other demyelinating neuropathies, such as CMT1, also cause nerve enlargement (3) . The present case did not have a family history or a duplicated PMP22 gene or MPZ gene mutation. Moreover, spontaneous recovery in childhood and abnormal temporal dispersions in the intermediate nerve segment, which were recognized as "non-uniform demyelination", are unlikely in hereditary demyelinating neuropathies. Cranial nerve hypertrophy is a rare manifestation of CIDP; involvement of the oculomotor (4) and trigeminal (frontal and infraorbital) nerves (4-8) has been previously reported. A pathology study found interstitial amorphous substances in the endoneurium and onion bulb formations in the enlarged nerves (9) .
In the present case, hypertrophy of the intraosseous inferior alveolar nerves was revealed following a finding of an enlarged mandibular canal. An enlarged mandibular canal is commonly observed with several types of neoplasms (10, 11) . Ethunandan et al. described a patient with a hypertrophic inferior alveolar nerve (12) . An open biopsy was performed on this patient and onion-bulb formation and diffuse lymphocyte infiltration, particularly around blood vessels, were found (12) . The patient was diagnosed with "localized hypertrophic neuropathy". Although the patient presented with no neurologic deficits other than numb-chin syndrome, radiological information for other parts of the patient's body was not available. In the present case, childhood onset was the possible cause of the bone change. Brachial plexus and ulnar nerve hypertrophy on MRI and ultrasonography supported the diagnosis of CIDP. CIDP should be considered as one of the causes of inferior alveolar nerve hypertrophy and mandibular canal enlargement.
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